ArticleFuture oncology (London, England)2024

Physician preferences of biomarker testing strategies in newly diagnosed stage IV non-small cell lung cancer patients.

Anne Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.